We hope you’ll tune in to the next installment of theMIT Sloan Expert Series.
Join us on February 15th, 12 noon to 12:30 ET for a live conversation with Chris Knittel, professor of applied economics at MIT Sloan, who will talk about his latest research on racial bias in the sharing economy—how Uber and Lyft are failing black passengers and what to do about it.
Eva Millona, the Executive Director of the Massachusetts Immigrant and Refugee Advocacy Coalition (MIRA), will also appear on the program to discuss ways Uber and Lyft can work on mitigating discrimination.
You will be able to view the live show by bookmarking this site and tuning in February 15th at 12 noon ET.
Submit your questions to #MITExpert on Twitter before 11 am ET on Feb. 15th. Your question could be answered live on the air.
Christopher Knittel is the George P. Shultz Professor and a Professor of Applied Economics at the MIT Sloan School of Management.
On January 20, 2017, Donald Trump will be sworn in as the 45th president of the United States. I say “sworn in,” rather than “assume the presidency,” because, under Section I of Article II of the US Constitution, Trump cannot actually become president unless he takes an oath of office, publicly committing himself to uphold the Constitution and perform to the best of his ability while in office. That is, of course, the case for all presidents. But, given how Trump comported himself during the campaign, it is particularly meaningful in his case.
Until now, Trump has made no effort to behave in an honest or reliable way. Technically, he didn’t have to. The US does not require any sworn statements from the men and women who run for president, nor does it have any enforceable code of behavior or constraints on the kind of rhetoric that can be used. Candidates may conduct themselves however they see fit.
This approach is based on the assumption that we can trust the candidates’ judgment. People seeking the country’s highest office should know how to balance the political imperative of winning votes with a sense of responsibility for the feasibility of – and reasoning behind – their policy promises.
By and large, experience has vindicated this view. The US has had the good fortune of choosing largely from among presidential aspirants who adhere to generally accepted norms. With Trump, it seems that fortune has turned into bankruptcy.
Thanks to the revolution in biologic therapy, the annual number of intravenous infusions at the Massachusetts General Hospital (MGH) rheumatology clinic’s small (two-chair) infusion center increased from 1,247 to 1,856 between 2009 and 2014. Related billings skyrocketed from nearly $16 million to more than $40 million. To understand this major shift, one must pause briefly to appreciate the medical history that led to it and then to examine how MGH is redesigning its care processes to bring these novel therapies to patients. Central to the plan is a collaboration with academic partners at the MIT Sloan School of Management.
The Medical Backstory
In 1980, a rheumatoid arthritis (RA) patient at the MGH rheumatology clinic would have received a weekly in-clinic infusion of gold salts and, occasionally, undergone laboratory monitoring.
The DC. Court of Appeals began hearing arguments recenlty in an historic session taken “en banc” – with a roster of 10 judges hearing a case that challenges President Obama’s Clean Power plan. Specifically, some industry associations are challenging new targets for coal plants that would require a 32 percent reduction in carbon emission by 2030. More generally, the case highlights challenges to Obama’s use of his executive powers to regulate the electricity industry in a way that will help the US meet international targets for reduction in carbon emissions.
While it may take weeks or even months for the court to rule, the case highlights the extreme importance of keeping U.S. plans to reduce emissions on track in order to spur continued global cooperation on global warming. With the U.S. election continuing to create its own heat, there are many interlocking and swiftly moving pieces on the global climate change front.
The world needs continued leadership from the U.S. and a ruling by the court that Obama had overreached would impact progress globally.
The holiday period is a great time for reflection and then behavior modification – often referred to as resolutions. While a bit artificial to the logical engineer, this opportunity can be helpful. This year, my favorite insight came from a former student and employee, Elliot Cohen, co-founder of PillPack.
While thinking about the major aspirational goals for the upcoming year that motivate me to get out of bed every morning with high energy and purpose – such as getting my second book out in March, significantly raising the endowment of the Martin Trust Center for MIT Entrepreneurship, developing the concept of “Inclusive Entrepreneurship” to battle the deep societal alienation we have seen in 2016, and, of course, just becoming a better entrepreneurship educator to my students – there is one underlying enabling resolution that can help me achieve all of them more efficiently and effectively.